How do you manage neuropathy from chemo?
Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent and often distressing side effect of cancer treatment that affects the nerves. Common symptoms of CIPN are numbness, tingling, burning pain, and muscle weakness, which often occur in the hands and feet. In this article, we will explore why CIPN happens, how long it lasts, and what can help relieve or reverse symptoms.
What Causes Neuropathy from Chemo?
Chemotherapy-induced neuropathy is primarily caused by the toxic effects of certain chemotherapy drugs on the peripheral nervous system. Agents such as platinum-based drugs (e.g., cisplatin, oxaliplatin), taxanes (e.g., paclitaxel, docetaxel), vinca alkaloids, bortezomib (Velcade), and thalidomide are most commonly associated with CIPN. These drugs can damage sensory, motor, and autonomic nerves, often by disrupting microtubules, mitochondrial function, or causing oxidative stress. These effects ultimately impair nerve signaling and health.
Symptoms of chemotherapy-induced peripheral neuropathy (CIPN) can appear at various times, depending on the specific chemotherapy agent and individual patient factors. Many patients develop CIPN within one month of starting chemotherapy, but others may not experience symptoms until later in treatment. In some cases, CIPN can worsen or persist in the weeks or months following the completion of chemotherapy, a phenomenon sometimes referred to as "coasting". The severity depends on drug type, dosage, and patient factors.
What Are the Symptoms of Chemo-Induced Neuropathy?
Symptoms of CIPN can vary in severity and presentation, but commonly include:
- Numbness or tingling, often starting in the hands and feet (glove and stocking distribution)
- Burning or shooting pain
- Increased sensitivity to touch, temperature, or pain
- Muscle weakness or cramps
- Loss of coordination or balance
- Autonomic symptoms (e.g., changes in blood pressure, bowel problems, bladder problems)
- In severe cases, motor impairment affecting daily activities
These symptoms can significantly impact quality of life and may require dose reductions or discontinuation of chemotherapy.
How Long Does Neuropathy from Chemo Last?
The duration of CIPN varies widely. For many patients, symptoms begin during treatment and may persist for months or even years after chemotherapy ends. For some patients, symptoms may last lifelong. Studies show that:
- About 31% of patients still report symptoms two months after completing chemotherapy for breast cancer.
- 58% of patients may experience symptoms six months after treatment with oxaliplatin for colorectal cancer, 45% at 12 months, and 24% at 36 months.
- Approximately 30–40% of patients develop chronic neuropathy that can last long-term.
Early management may improve outcomes. It is important to tell your cancer care team right away if you notice any symptoms of nerve problems.
Can Neuropathy from Chemo Be Reversed?
While some patients experience partial or complete recovery after stopping chemotherapy, a significant proportion continue to have persistent symptoms. The likelihood of reversal depends on the chemotherapy agent, dose, duration, and individual patient factors. Although neuropathy may improve over time, about one-third of patients face chronic symptoms that do not fully resolve. There are currently no guaranteed methods to reverse CIPN, but ongoing research aims to develop more effective treatments.
Current treatments for CIPN may include:
- Duloxetine (Cymbalta): an antidepressant that is currently the most evidence-based medication for moderate CIPN symptom relief
- Other antidepressants, anticonvulsants (e.g., gabapentin), and topical agents (such as high-concentration capsaicin) may provide benefit for some patients
- Lidocaine patches
- Physical and occupational therapy
- Supplements (B-vitamins, under doctor supervision).
- Scrambler therapy
- Complementary approaches, such as acupuncture, have shown some promise but require further study
How to Manage and Relieve Neuropathy Symptoms?
Currently, there are no proven strategies to prevent CIPN, but early detection and dose adjustment may help limit severity. Management of neuropathy symptoms may include a combination of treatments, including pharmacological approaches and lifestyle measures. Some ways you can relieve symptoms due to CIPN include:
- Keep extremities warm to reduce sensitivity.
- Practice balance exercises and physical therapy.
- Use assistive devices for mobility if needed.
- Protect affected areas from injury (e.g., wear shoes).
- Check your hands and feet daily to see if they have any injuries.
- Set hot water heaters between 105° to 120°F.
- Avoid alcohol, which can worsen nerve damage.
- Discuss medications and alternative therapies with your doctor regularly.
Conclusion
Managing chemotherapy-induced neuropathy involves a combination of symptom relief, supportive care, and ongoing research into more effective treatments. While some patients recover, many experience long-term symptoms, making early recognition essential for improving quality of life. Notify your healthcare provider right away if you experience any signs or symptoms of neuropathy.
References
- American Cancer Society. 2025. Peripheral Neuropathy. Accessed on May 26, 2025 at https://www.cancer.org/cancer/managing-cancer/side-effects/pain/peripheral-neuropathy.html
- Burgess, J., et. al. 2021. Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment. Oncology and therapy, 9(2), 385–450. https://doi.org/10.1007/s40487-021-00168-y
- Desforges, A. D., et. al. 2022. Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: An update. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 147, 112671. https://doi.org/10.1016/j.biopha.2022.112671
- Maihöfner, C.,et. al. 2021. Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 29(8), 4223–4238. https://doi.org/10.1007/s00520-021-06042-x
- Oyekan, A. O., et. al. 2024. Prevalence and predictors of chemotherapy-induced peripheral neuropathy among female breast cancer patients undergoing chemotherapy in Lagos. Ecancermedicalscience, 18, 1791. https://doi.org/10.3332/ecancer.2024.1791
- Renting, L., et. al. 2024. Vitamin B6 status and chronic chemotherapy-induced peripheral neuropathy: a prospective cohort study among patients with non-metastatic colorectal cancer receiving oxaliplatin-based chemotherapy. In: BMJ Oncology. DOI: https://doi.org/10.1136/bmjonc-2024-000462
- Starobova, H., et. al. 2017. Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy. Frontiers in molecular neuroscience, 10, 174. https://doi.org/10.3389/fnmol.2017.00174
- Teng, C., et. al. 2022. "POLAR-izing" Findings From Trials of Neuroprotection for Oxaliplatin Neuropathy. JNCI cancer spectrum, 6(6), pkac076. https://doi.org/10.1093/jncics/pkac076
- Tsai, C. H., et. al. 2021. Integrated Medicine for Chemotherapy-Induced Peripheral Neuropathy. International journal of molecular sciences, 22(17), 9257. https://doi.org/10.3390/ijms22179257
See also:
Imuran
Imuran is used for atopic dermatitis, autoimmune hepatitis, chronic active hepatitis, chronic ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Ruxience
Ruxience is a biosimilar to Rituxan and is used to treat certain leukemias and lymphomas and some ...
Azasan
Azasan is used for atopic dermatitis, autoimmune hepatitis, chronic active hepatitis, chronic ...
Riabni
Riabni is a biosimilar to Rituxan and is used to treat certain leukemias and lymphomas and some ...
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Dexamethasone Intensol
Dexamethasone Intensol is used for addison's disease, adrenal insufficiency, adrenocortical ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Darzalex
Darzalex (daratumumab) is a target therapy used to treat multiple myeloma. Includes DARZALEX uses ...
Velcade
Velcade injection is used to treat multiple myeloma and mantle cell lymphoma. Includes Velcade side ...
Pomalyst
Pomalyst (pomalidomide) is used to treat multiple myeloma and AIDS-related Kaposi sarcoma. Includes ...
Related medical questions
- Is gabapentin addictive?
- Should gabapentin be taken with food?
- Does carboplatin cause neuropathy?
- Does Qutenza contain red chili peppers?
Related support groups
- Peripheral Neuropathy (105 questions, 835 members)